HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 2,500 shares, a growth of 56.3% from the September 30th total of 1,600 shares. Based on an average daily volume of 9,800 shares, the short-interest ratio is currently 0.3 days.
HAVN Life Sciences Trading Up 39.4 %
HAVLF stock traded up $0.03 during trading on Friday, hitting $0.09. 3,415 shares of the stock traded hands, compared to its average volume of 4,465. HAVN Life Sciences has a one year low of $0.05 and a one year high of $6.66. The company has a 50 day simple moving average of $0.19 and a 200 day simple moving average of $0.92.
Get HAVN Life Sciences alerts:HAVN Life Sciences Company Profile
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Featured Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
- Apple Inc. Stock Q4 Results Beat Negative Outlook, Stock Rises
- Chevron Gushes More Profits; Is it Time for Investors to Buy?
- Can Comcast Monetize Existing Users for Streaming Success?
- Why is Amazon Stock Falling? Is the Sell-Off Overdone?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.